Eiken Chemical Co., Ltd.
Basic information
- Head office
- 20th floor, Sora City, 4-6-6 Kanda Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan
- Chief executive
- Yusuke Segawa
- Capital
- 6,897,730,000 (68 100 million)
- Employees (non-consolidated)
- 700 people
- Employees (consolidated)
- 696 people
- Start date
- 1939-02-20
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| 日本栄養化学株式会社 | ||||||||
| 日本臨床検査薬協会 | ||||||||
| 栄研生物科技(上海)有限公司 | ||||||||
| 株式会社興亜化学工業株式会社 | ||||||||
| Kokua Nutrition Chemistry Laboratory Inc. | ||||||||
| 関西医薬品協会 | ||||||||
| HUMAN社 | ||||||||
| AVI JAPAN OPPORTUNITY TRUST PLC | ||||||||
| CACEIS BANK, LUXEMBOURG BRANCH / AIF CLIENTS ASSETS | ||||||||
| GOLDMAN,SACHS & CO.REG | ||||||||
| NAVF SELECT LLC | ||||||||
|
|
||||||||
| THE BANK OF NEW YORK - JASDECTREATY ACCOUNT | ||||||||
|
|
||||||||
|
|
||||||||
| 栄研生物科技(中国)有限公司 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
Network
History
Founded
Founded as Kōa Chemical Industries Co., Ltd. by Kurozumi Gō (Katsushika-ku, Tokyo)
Commenced manufacturing and sale of nutritional foods and pharmaceuticals derived from livestock organs
Renamed to Kōa Nutrition Chemical Research Institute Inc.
Entered into a joint sales agreement and capital partnership with Tanabe Pharmaceutical Co., Ltd.
Renamed to Nihon Nutrition Chemical Co., Ltd.
Commenced sales of bacterial testing products
Bacterial testing powder medium 'SS Agar Medium Eiken'
Successfully commercialized 'SS Agar Medium' (for isolation of Shigella and typhoid bacteria), contributing to national public health and disease prevention.
Renamed to Eiken Chemical Co., Ltd. on the 30th anniversary of its founding
Released live medium 'Poamedia'
Eiken Immunochemical Research Institute (Kita-ku, Tokyo: Oji branch) completed and commenced operations
Released radioimmunoassay (RIA) related reagents
Released latex agglutination slide reagents
Gestate Slide 'Eiken'
Released bacterial identification reagents
Released immunoserum test reagents developed with a pioneering method that does not dilute samples
RA77 'Eiken'
New headquarters building (Bunkyo-ku, Tokyo) completed and operations commenced
Established the Kurozumi Medical Research Promotion Foundation and awarded the first research grant
Released chemiluminescent enzyme immunoassay device 'LumiSpot AL-1000' and dedicated reagents
Commenced overseas expansion of fecal occult blood test reagents and measuring devices
Released fecal occult blood test reagents using immunochromatography
OC-HemoCatch 'Eiken'
Released fully automatic urine analysis devices 'US-3100' and 'US-3200' and dedicated reagents 'UroPaper αII Eiken'
Announced development of new gene amplification technology LAMP method
Released urine automatic analysis device 'US-2100R'
Released fecal occult blood measurement device 'OC Sensor μ'
Ended sales agreement with Tanabe Pharmaceutical and began in-house sales of clinical test reagents and devices (terminated capital partnership in 2007)
Released fecal occult blood measurement device 'OC Sensor neo'
Released fully automatic urine analysis device 'US-3100R'
Established Eiken Biological Technology (Shanghai) Co., Ltd.
Obtained ISO 13485 and ISO 9001 certifications
Signed a joint development agreement for a rapid genetic test for tuberculosis using FIND and LAMP methods
Released urine automatic analysis device 'US-1000'
Entered into a business and capital partnership with Otsuka Pharmaceutical Co., Ltd.
Released bacterial antibiotic susceptibility test reagent 'Dry Plate Eiken 192'
Participated in the Brave Circle colorectal cancer eradication campaign
Released fecal occult blood measurement device 'OC Sensor DIANA'
Absorbed and merged with Eiken Equipment Co., Ltd.
Released fully automatic analysis device 'US-3300'
Tetsuya Teramoto appointed as Representative Executive President
News
There is no news.
Public records
National Tax Agency basic information2010501028231
- Trade name
- 栄研化学株式会社
- Trade name (kana)
- エイケンカガク
- Name in English
- Corporation type
- 301
- Address
- 〒101-0062 東京都千代田区神田駿河台４丁目６番地
- Postal code
- 1010062
- Prefecture code
- 13
- City code
- 101
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2025-09-25
- Change date
- 2025-09-19
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 12
- Correction type
- 0
- Trade name image ID
- Address image ID
- Sequence number
- 1462923
METI gBizINFO2010501028231
- Corporate number
- 2010501028231
- Trade name
- 栄研化学株式会社
- Trade name (kana)
- エイケンカガク
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 東京都千代田区神田駿河台４丁目６番地
- Postal code
- 1010062
- Prefecture
- 東京都
- Prefecture code
- 13
- City or district
- 千代田区
- City code
- 101
- Street address
- 神田駿河台４丁目６番地
- Organisation type
- 301
- Processing type
- 12
- Correction type
- 0
- Status
- Representative
- 代表執行役社長 瀨川 雄司
- Capital
- 6897000000
- Employees
- 1047
- Employees (male)
- 641
- Employees (female)
- 406
- Business summary
- 医薬品、試薬、医療および理化学機械器具などの製造、販売ならびに輸出入販売
- Website URL
- https://www.eiken.co.jp/sustainability/social/engagement/
- Year founded
- Business category
- E:製造業
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2025-09-25
- Key information
- 2010501028231